BSE filing, NSE: SSDL. Summary written from the filing by ALFA Finder's alert engine.
Saraswati Saree Depot Ltd: key numbers
- Share price
- ₹68.00
- Market cap
- ₹269.3 Cr
- Revenue (annual)
- ₹631.2 Cr
- Net profit (annual)
- ₹23.41 Cr
- P/E (TTM)
- 11.4×Sector 49.5×
- Promoter holding
- 74.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saraswati Saree Depot Ltd
All →Saraswati Saree Depot Legal & Regulatory
Saraswati Saree Depot received a GST order imposing a penalty of ₹0.32 Crore. The company intends to contest the demand, citing reasonable merit in its favor.
- Value
- ₹0.32 Cr
Saraswati Saree Depot Dividend
Saraswati Saree Depot declared an interim dividend of ₹0.30 per equity share for FY 2026-27. The record date is fixed for September 30, 2026.
Saraswati Saree Depot Dividend
Saraswati Saree Depot Limited declared an interim dividend of ₹3.00 per share for FY 2026-27, amounting to a total payout of ₹11.88 Crore.
- Value
- ₹11.88 Cr
Saraswati Saree Depot Board Meeting Date
Saraswati Saree Depot will hold a board meeting on September 24, 2026, to consider and approve an interim dividend and fix the record date.
Saraswati Saree Depot Management Change
Saraswati Saree Depot Ltd's shareholders approved the appointment of Statutory Auditor PPC & Co. and the re-appointment of Independent Directors at the recent AGM.
Saraswati Saree Depot Annual General Meeting
Saraswati Saree Depot Limited held its 6th Annual General Meeting on September 18, 2026, to conduct routine business including financial statement adoption and director appointments.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.